相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
Karl Kieburtz et al.
ARCHIVES OF NEUROLOGY (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities
Herve Schaffhauser et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
Pedro R. Lowenstein et al.
CURRENT GENE THERAPY (2009)
Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task
Jerry J. Buccafusco et al.
PSYCHOPHARMACOLOGY (2009)
Lost in translation: Problems and pitfalls in translating laboratory observations to clinical utility
Richard Simon
EUROPEAN JOURNAL OF CANCER (2008)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Evaluation of Dimebon in cellular model of Huntington's disease
Jun Wu et al.
MOLECULAR NEURODEGENERATION (2008)
The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates
Jerry J. Buccafusco et al.
PSYCHOPHARMACOLOGY (2008)
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping
Mark D. Lindner et al.
PSYCHOPHARMACOLOGY (2006)
Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: Deficits induced by scopolamine and by prolonging the retention interval
Natasja de Bruin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
CNS targets for multi-functional drugs in the treatment of Alzheimers and Parkinsons diseases
MBH Youdim et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats
FJ van der Staay et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
MBH Youdim et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Drug therapy - Alzheimer's disease
JL Cummings
NEW ENGLAND JOURNAL OF MEDICINE (2004)
5-ht(6) Receptors
Marie L. Woolley et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Memory-related task performance by aged rhesus monkeys administered the muscarinic M1-preferring agonist, talsaclidine
AV Terry et al.
PSYCHOPHARMACOLOGY (2002)
Dimebon improves learning in animals with experimental Alzheimer's disease
NN Lermontova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
分享论文
